ESM-1 Regulates PI3K-AKT-mTOR Signaling to Promote the Progression of Cervical Cancer

被引:0
|
作者
Zhu, Zhengxia [1 ]
Zhang, Jianyang [2 ]
Wu, Peng [1 ,3 ]
机构
[1] Zhejiang Xiaoshan Hosp, Dept Gynecol Oncol, Hangzhou, Peoples R China
[2] Zhejiang Univ, Womens Hosp Sch Med, Dept Gynecol, Hangzhou, Peoples R China
[3] 10th Floor, Bldg 1, 728 Yucai North Rd, Hangzhou, Zhejiang, Peoples R China
关键词
cervical cancer; ESM-1; invasion; mi-gration; PI3K-AKT-mTOR signaling pathway; pro-liferation; CELL SPECIFIC MOLECULE-1; ENDOCAN; GROWTH; EXPRESSION;
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
OBJECTIVE: To study the effect of endothelial cell-specific molecule-1 (ESM-1) on the biological behavior of cervical cancer cells and the molecular mechanism involved.STUDY DESIGN: qRT-PCR was used to detect ESM-1 expression in cervical cancer tissues and normal tissues adjacent to cancer, human normal cervical epithelial cell lines (H8), and human cervical cancer cell lines (HeLa, CaSki, C-33A, and SiHa). After silencing ESM-1 expression in C-33A and SiHa cells, MTT, flow cytom-etry, and Transwell assay were administered to measure cell proliferation, apoptosis, invasion, and migration, respectively. ESM-1 protein expression in tissues and PI3K-AKT-mTOR pathway related protein in cervical cancer cells were detected by western blot.RESULTS: ESM-1 expression was upregulated signifi-cantly in cervical cancer tissues and cells. Knockdown of ESM-1 inhibited the proliferation, invasion, and mi-gration of cervical cancer cells, promoted cancer cell apoptosis, and significantly inhibited the activation of PI3K-AKT-mTOR signaling pathway. Additionally, knockdown of ESM-1 restrained the cancer-promoting effect of the PI3K activator (740Y-P) on cells.CONCLUSION: Knockdown of ESM-1 can inhibit the activation of PI3K/Akt/mTOR signaling pathway to hinder cell proliferation, invasion, and migration. Mean- while, knockdown of ESM-1 can promote cervical cancer cell apoptosis and slow down the development of cervi-cal cancer. Additionally, it can be used as a molecular target for the treatment and prognosis of cervical cancer. (Anal Quant Cytopathol Histpathol 2021;43:901- 908)
引用
收藏
页码:901 / 908
页数:8
相关论文
共 50 条
  • [11] PI3K-AKT-mTOR inhibition in cancer immunotherapy, redux
    O'Donnell, Jake S.
    Massi, Daniela
    Teng, Michele W. L.
    Mandala, Mario
    SEMINARS IN CANCER BIOLOGY, 2018, 48 : 91 - 103
  • [12] Ziprasidone triggers inflammasome signaling via PI3K-Akt-mTOR pathway to promote atrial fibrillation
    Lu, Ming-Kun
    Huo, Yen-Nien
    Tai, Buh-Yuan
    Lin, Chih-Yuan
    Yang, Hsiang-Yu
    Tsai, Chien-Sung
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 175
  • [13] SUGT1 regulates the progression of ovarian cancer through the AKT/PI3K/ mTOR signaling pathway
    Ke, Miao
    Xu, Jie
    Ouyang, Ye
    Chen, Junyu
    Yuan, Donglan
    Guo, Ting
    TRANSLATIONAL ONCOLOGY, 2024, 49
  • [14] PI3K-AKT-mTOR pathway inhibitors
    Cortot, A
    Armand, JP
    Soria, JC
    BULLETIN DU CANCER, 2006, 93 (01) : 19 - 26
  • [15] Dysregulated lncRNA-UCA1 contributes to the progression of gastric cancer through regulation of the PI3K-Akt-mTOR signaling pathway
    Li, Chengyun
    Liang, Geyu
    Sui, Jing
    Yang, Sheng
    Xu, Siyi
    TOXICOLOGY LETTERS, 2017, 280 : S239 - S240
  • [16] Paeonol regulates autophagy through the PI3K-AKT-mTOR signaling pathway to inhibit apoptosis of osteocytes
    Gong, Shuwei
    Tian, Aixian
    Lang, Shuang
    Wang, Yan
    Ma, Jianxiong
    Ma, Xinlong
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2025, 995
  • [17] Dysregulated lncRNA-UCA1 contributes to the progression of gastric cancer through regulation of the PI3K-Akt-mTOR signaling pathway
    Li, Chengyun
    Liang, Geyu
    Yang, Sheng
    Sui, Jing
    Yao, Wenzhuo
    Shen, Xian
    Zhang, Yanqiu
    Peng, Hui
    Hong, Weiwei
    Xu, Siyi
    Wu, Wenjuan
    Ye, Yancheng
    Zhang, Zhiyi
    Zhang, Wenhua
    Yin, Lihong
    Pu, Yuepu
    ONCOTARGET, 2017, 8 (55) : 93476 - 93491
  • [18] TCP1 regulates PI3K/AKT/mTOR signaling pathway to promote proliferation of ovarian cancer cells
    Huixi Weng
    Xiushan Feng
    Yu Lan
    Zhiqun Zheng
    Journal of Ovarian Research, 14
  • [19] The PI3K-AKT-mTOR Pathway and Prostate Cancer: At the Crossroads of AR, MAPK, and WNT Signaling
    Shorning, Boris Y.
    Dass, Manisha S.
    Smalley, Matthew J.
    Pearson, Helen B.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (12) : 1 - 47
  • [20] TCP1 regulates PI3K/AKT/mTOR signaling pathway to promote proliferation of ovarian cancer cells
    Weng, Huixi
    Feng, Xiushan
    Lan, Yu
    Zheng, Zhiqun
    JOURNAL OF OVARIAN RESEARCH, 2021, 14 (01)